Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment.

J Clin Med · 2023 · PMC10488336 · PMID 37685664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

When compared to placebo or reference therapy, vildagliptin had a marginally significant beneficial effect on liver fat and showed a mild reduction in serum ALT levels, whereas sitagliptin did not.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.